O.O. Melnyk

1.9k total citations
27 papers, 1.6k citations indexed

About

O.O. Melnyk is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, O.O. Melnyk has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in O.O. Melnyk's work include Lung Cancer Treatments and Mutations (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Lung Cancer Research Studies (3 papers). O.O. Melnyk is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Lung Cancer Research Studies (3 papers). O.O. Melnyk collaborates with scholars based in United States, Canada and Belgium. O.O. Melnyk's co-authors include Richard C. Harvey, John B. Faust, T C Meeker, Kate A. Carey, D A Withers, Roy S. Herbst, Timothy P. L. Roberts, Jeffry S. Mann, Christine D. Pham and Nick van Bruggen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

O.O. Melnyk

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O.O. Melnyk United States 12 754 749 501 326 309 27 1.6k
Rajiv Bassi United States 19 925 1.2× 783 1.0× 373 0.7× 280 0.9× 288 0.9× 26 1.7k
Shyhmin Huang United States 23 1.1k 1.4× 1.5k 2.0× 1.0k 2.0× 291 0.9× 380 1.2× 39 2.4k
Toni M. Brand United States 19 720 1.0× 807 1.1× 365 0.7× 186 0.6× 213 0.7× 27 1.5k
Genichiro Ishii Japan 30 588 0.8× 997 1.3× 1.3k 2.7× 425 1.3× 332 1.1× 95 2.6k
Xenia Jimenez United States 22 1.2k 1.6× 670 0.9× 227 0.5× 280 0.9× 630 2.0× 27 1.7k
Patricia LoRusso United States 21 896 1.2× 1.1k 1.5× 353 0.7× 228 0.7× 405 1.3× 66 2.0k
Birgit M. Kräling United States 10 986 1.3× 739 1.0× 256 0.5× 551 1.7× 95 0.3× 12 1.9k
Dan Laheru United States 19 505 0.7× 1.4k 1.9× 351 0.7× 298 0.9× 107 0.3× 69 2.1k
Leonardo Faoro United States 16 686 0.9× 691 0.9× 344 0.7× 192 0.6× 70 0.2× 36 1.6k
Takafumi Sangai Japan 26 877 1.2× 979 1.3× 317 0.6× 444 1.4× 115 0.4× 78 2.1k

Countries citing papers authored by O.O. Melnyk

Since Specialization
Citations

This map shows the geographic impact of O.O. Melnyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O.O. Melnyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O.O. Melnyk more than expected).

Fields of papers citing papers by O.O. Melnyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O.O. Melnyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O.O. Melnyk. The network helps show where O.O. Melnyk may publish in the future.

Co-authorship network of co-authors of O.O. Melnyk

This figure shows the co-authorship network connecting the top 25 collaborators of O.O. Melnyk. A scholar is included among the top collaborators of O.O. Melnyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O.O. Melnyk. O.O. Melnyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Melnyk, O.O., et al.. (2022). ECONOMIC AND MATHEMATICAL TOOLS FOR PREDICTING THE CURRENCY EXCHANGE RATE. Scientific opinion Economics and Management.
3.
4.
Melnyk, O.O.. (2018). Фокально-сегментарний гломерулосклероз: генетичний аналіз і цільова терапія. SHILAP Revista de lepidopterología. 7(1). 35–49. 2 indexed citations
5.
Melnyk, O.O.. (2017). Кардіоренальний синдром: діагностика та лікування. SHILAP Revista de lepidopterología. 6(1). 2–14. 2 indexed citations
6.
Melnyk, O.O.. (2017). Метаболічний синдром і ризик хронічної хвороби нирок. SHILAP Revista de lepidopterología. 6(2). 80–90. 4 indexed citations
7.
Melnyk, O.O.. (2016). Disorders of Lipid Metabolism and its Correction in Chronic Kidney Disease. SHILAP Revista de lepidopterología. 85–95. 2 indexed citations
8.
9.
10.
Leighl, Natasha B., Luis E. Raez, Benjamin Besse, et al.. (2010). A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung. Journal of Thoracic Oncology. 5(7). 1054–1059. 68 indexed citations
11.
Vergote, Ignace, Neil J. Finkler, James B. Hall, et al.. (2010). Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer. International Journal of Gynecological Cancer. 20(5). 772–780. 47 indexed citations
12.
13.
Sequist, Lecia V., Panos Fidias, Jennifer S. Temel, et al.. (2009). Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(11). 1389–1396. 18 indexed citations
14.
Massarelli, Erminia, V.A. Miller, Natasha B. Leighl, et al.. (2007). Phase II study of the efficacy and safety of intravenous (IV) AVE0005 (VEGF Trap) given every 2 weeks in patients (Pts) with platinum- and erlotinib- resistant adenocarcinoma of the lung (NSCLA). Journal of Clinical Oncology. 25(18_suppl). 7627–7627. 33 indexed citations
15.
16.
17.
Pham, Christine D., Timothy P. L. Roberts, Nick van Bruggen, et al.. (1998). Magnetic Resonance Imaging Detects Suppression of Tumor Vascular Permeability After Administration of Antibody to Vascular Endothelial Growth Factor. Cancer Investigation. 16(4). 225–230. 173 indexed citations
18.
Brasch, Robert C., Christine D. Pham, David M. Shames, et al.. (1997). Assessing tumor angiogenesis using macromolecular MR imaging contrast media. Journal of Magnetic Resonance Imaging. 7(1). 68–74. 221 indexed citations
19.
Withers, D A, Richard C. Harvey, John B. Faust, et al.. (1991). Characterization of a candidate bcl-1 gene.. Molecular and Cellular Biology. 11(10). 4846–4853. 291 indexed citations
20.
Withers, Donald A., Richard C. Harvey, John B. Faust, et al.. (1991). Characterization of a Candidate bcl-1 Gene. Molecular and Cellular Biology. 11(10). 4846–4853. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajiv Bassi Breakdown of academic impact, for papers by Shyhmin Huang Breakdown of academic impact, for papers by Toni M. Brand Breakdown of academic impact, for papers by Genichiro Ishii Breakdown of academic impact, for papers by Xenia Jimenez Breakdown of academic impact, for papers by Patricia LoRusso Breakdown of academic impact, for papers by Birgit M. Kräling Breakdown of academic impact, for papers by Dan Laheru Breakdown of academic impact, for papers by Leonardo Faoro Breakdown of academic impact, for papers by Takafumi Sangai
Rankless by CCL
2026